SABIC (2010) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
1 Jul, 2026Executive summary
Q1 2025 revenue was SAR 34.6 billion ($9.23 billion), flat sequentially and up 6% year-over-year, with stable demand in most end-product sectors.
Net loss was SAR 1.16 billion, improved sequentially but down year-over-year, driven by higher costs, restructuring, and discontinued operations.
EBITDA was SAR 2.5 billion ($670 million), impacted by SAR 1.07 billion ($300 million) in one-time restructuring costs; adjusted EBITDA was SAR 3.7 billion ($1 billion), up 7% sequentially.
Strategic workforce optimization and restructuring initiatives are expected to yield over $90 million in annual cost savings.
Major growth projects in China and Saudi Arabia are progressing on schedule, with sustainability milestones and multiple Edison Awards achieved.
Financial highlights
Revenue: SAR 34.6 billion ($9.23 billion), flat quarter-over-quarter, up 6% year-over-year.
EBITDA: SAR 2.5 billion ($670 million), down 30% sequentially and 45% year-over-year; adjusted EBITDA (excluding special items): SAR 3.7 billion ($1 billion), up 7% sequentially.
Net loss: SAR 1.16 billion, improved from SAR 1.84 billion last quarter, but down from net income a year ago.
Free cash flow was negative at SAR 1.35 billion, reflecting lower cash from operations and restructuring costs.
Gearing ratio improved to 0.48%, supporting dividend commitments and capital investments.
Outlook and guidance
2025 capital investment projected at $3.5–4.0 billion, focused on operational excellence, transformation, and selective growth.
Guidance based on slow global economic growth, with GDP growth expected at 2.2–2.97%.
Demand expected to remain stable across sectors in the next quarter.
Latest events from SABIC
- EBITDA and net income rose despite lower revenue, with higher margins and innovation gains.2010
Q4 20249 Jul 2026 - Q2 2024 net income jumped 85% YoY on higher sales, margin gains, and portfolio optimization.2010
Q2 20248 Jul 2026 - Q3 2024 revenue up 3% YoY, net income rebounded, and major divestments drove portfolio gains.2010
Q3 20241 Jul 2026 - Revenue fell but EBITDA margin and cash flow remained strong amid persistent overcapacity.2010
Q3 20251 Jul 2026 - Adjusted EBITDA jumped 40% in Q2 2025, but net loss reflects major impairment charges.2010
Q2 20251 Jul 2026 - Adjusted EBITDA rose 25% to $1.1B (SAR 4.15B) despite a 6% revenue drop, driven by cost and pricing gains.2010
Q1 20261 Jul 2026 - Adjusted profits remained resilient and free cash flow rose 17% despite margin pressure.2010
Q4 20255 Mar 2026